Hikma Pharmaceuticals (LON:HIK) Shares Cross Above 200-Day Moving Average – Here’s What Happened

Hikma Pharmaceuticals PLC (LON:HIK) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,921.36 ($24.09) and traded as high as GBX 2,000 ($25.07). Hikma Pharmaceuticals shares last traded at GBX 1,991.27 ($24.96), with a volume of 387,164 shares trading hands.

Analyst Ratings Changes

Separately, Berenberg Bank raised shares of Hikma Pharmaceuticals to a “buy” rating and upped their price target for the company from GBX 2,100 ($26.33) to GBX 2,400 ($30.09) in a research report on Monday, September 2nd.

Hikma Pharmaceuticals Price Performance

The firm has a 50 day moving average of GBX 1,911.66 and a 200-day moving average of GBX 1,921.36. The company has a current ratio of 1.66, a quick ratio of 1.27 and a debt-to-equity ratio of 55.48. The company has a market cap of £4.42 billion, a P/E ratio of 3,063.48, a P/E/G ratio of 2.38 and a beta of 0.41.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.